Healthcare Services / Healthcare Facilities
$00.00
ENSG
The Ensign Group, Inc. provides a comprehensive suite of skilled nursing, senior living, and rehabilitative services. Founded in 1999 and headquartered in San Juan Capistrano, California, the company has established itself as a significant player in the post-acute healthcare services sector. As of September 2025, its market capitalization stood at $9.16 billion, reflecting its substantial presence and market value.
The company operates through two primary segments: Skilled Services and Standard Bearer. Its independent operating subsidiaries are structured to provide a broad spectrum of healthcare-related services.
This segment focuses on direct patient care, offering both short-term and long-term nursing services. It caters to patients with chronic conditions, prolonged illnesses, and the elderly. Specialized care includes on-site dialysis, ventilator care, and comprehensive cardiac and pulmonary management. Standard services provided encompass room and board, tailored nutritional programs, social services, recreational activities, and entertainment, ensuring a holistic approach to patient well-being.
The Standard Bearer segment primarily involves real estate leasing. It leases post-acute care properties to healthcare operators. The company currently owns 140 properties within this segment. Of these, 106 are leased to an Ensign-affiliated operator, while 35 are leased to independent third-party operators. This segment demonstrates a strategic approach to real estate management within the healthcare ecosystem.
The Ensign Group extends its operational reach across a broad geographic footprint within the United States. The company operates its healthcare facilities in the following states:
- Alabama
- Alaska
- Arizona
- Colorado
- Idaho
- Iowa
- Kansas
- Oregon
- Nebraska
- Nevada
- South Carolina
- Tennessee
- Texas
- Utah
- Washington
- Wisconsin
This extensive presence allows the company to serve diverse communities and markets.
Beyond core nursing and senior living, The Ensign Group offers a range of ancillary and supportive services to enhance patient care and convenience. These include:
- Digital X-ray and ultrasound services
- Electrocardiograms (ECGs)
- Sub-acute services
- On-site dialysis
- Respiratory care
- Long-term care pharmacy services
- Patient transportation (both to facilities and to people in their homes)
- Mobile diagnostics
- Mobile X-ray services
- Non-emergency transportation services
These diversified services underscore the company's commitment to a comprehensive healthcare delivery model.
The Ensign Group has demonstrated robust financial growth and operational improvements.
For the fiscal year 2024, The Ensign Group reported impressive financial figures:
- Revenue: $4.26 billion, an increase of 14.24% compared to the previous year's $3.73 billion.
- GAAP Net Income: $298.0 million, marking a substantial increase of 42.3% year-over-year.
- Q4 GAAP Net Income: $79.7 million, up significantly by 267.4%.
- Adjusted Earnings Per Share (EPS): $5.50 for the full year (up 15.3%) and $1.49 for Q4 (up 16.4%).
The company's performance continued strongly into the first half of fiscal year 2025:
- Total Revenue: $1.23 billion, an increase of 18.5% from the previous year.
- GAAP Diluted EPS: $1.44 (up 18.0% Year-over-Year).
- Adjusted EPS: $1.59 (up 20.5% Year-over-Year).
Operational efficiency saw notable improvements:
- Same Facilities Occupancy: Reached 82.1%, an increase of 2.7% year-over-year.
- Transitioning Facilities Occupancy: Reached 84.0%, an increase of 4.1% year-over-year.
The Ensign Group's growth is fueled by strategic acquisitions and operational expansion:
- Acquisitions in 2024: The company acquired 38 operations, including 12 new operations in Q4 2024.
- New Operations Added: A total of 52 new operations have been added since early 2024.
- Liquidity: The company maintains strong financial health with $364.0 million in cash on hand, supporting its growth initiatives.
Ensign Group has provided positive financial outlooks for the upcoming periods:
- Initial 2025 Guidance: Projected earnings per diluted share of $6.16 to $6.34 and revenue guidance of $4.83 billion to $4.91 billion (representing a 13.8% increase at the midpoint over 2024 results).
- Raised 2025 Guidance: The company subsequently raised its 2025 guidance to $6.34-$6.46 EPS and $4.99-$5.02 billion in revenue.
The Ensign Group has a consistent history of returning value to shareholders:
- Forward Dividend & Yield: 0.25 (0.16%)
- Ex-Dividend Date: June 30, 2025
- Dividend History: Ms. Snapper highlighted the company's strong liquidity, enabling its plan to continue its long history of paying dividends. In December 2024, the company increased its dividend for the 22nd consecutive year.
The Ensign Group stands as a well-established healthcare services provider, characterized by a robust track record of growth driven by strategic acquisitions and consistent operational excellence. Its decentralized operating model empowers independent subsidiaries with local management autonomy while leveraging the resources and expertise of the broader organization. With sustained dividend increases spanning over two decades and solid financial performance, ENSG continues to solidify its position as a significant and reliable player in the post-acute healthcare services sector.